Securian Asset Management, Inc Pfizer Inc Transaction History

Securian Asset Management, Inc

$3.4 Billion
Q2 2024

A detailed history of Securian Asset Management, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Securian Asset Management, Inc holds 325,833 shares of PFE stock, worth $9.43 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

325,833

Previous 332,571 2.03%

Holding current value

$9.43 Million

Previous $9.23 Million 1.21%

% of portfolio

0.27%

Previous 0.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $170,201 - $199,444	-6,738 Reduced 2.03%	325,833 $9.12 Million
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $648,156 - $744,290	-25,035 Reduced 7.0%	332,571 $9.23 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $1.24 Million - $1.61 Million	-47,558 Reduced 11.74%	357,606 $10.3 Million
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $2.21 Million - $2.58 Million	-68,739 Reduced 14.5%	405,164 $13.4 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $94,273 - $109,071	-2,610 Reduced 0.55%	473,903 $17.4 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $77,637 - $101,072	1,971 Added 0.42%	476,513 $19.4 Million
Q4 2022 Feb 02, 2023	BUY	$41.75 - $54.5 $279,892 - $365,368	6,704 Added 1.43%	474,542 $24.3 Million
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $96,622 - $117,951	2,208 Added 0.47%	467,838 $20.5 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $140,799 - $166,944	-3,026 Reduced 0.65%	465,630 $24.4 Million
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $287,401 - $356,126	-6,282 Reduced 1.32%	468,656 $24.3 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $293,950 - $435,732	7,114 Added 1.52%	474,938 $28 Million
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $167,676 - $215,394	-4,272 Reduced 0.9%	467,824 $20.1 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $37,310 - $42,266	-1,039 Reduced 0.22%	472,096 $18.5 Million
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $475,156 - $535,880	-14,188 Reduced 2.91%	473,135 $17.1 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $618,057 - $785,912	-18,466 Reduced 3.65%	487,323 $17.9 Million
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $159,131 - $186,697	-5,012 Reduced 0.98%	505,789 $18.6 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $924,352 - $1.12 Million	-30,689 Reduced 5.67%	510,801 $16.7 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $253,622 - $362,371	-9,383 Reduced 1.7%	541,490 $17.7 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $900,987 - $1.02 Million	-27,369 Reduced 4.73%	550,873 $21.6 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $221,321 - $286,989	-6,812 Reduced 1.16%	578,242 $20.8 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $173,769 - $195,102	4,699 Added 0.81%	585,054 $25.3 Million
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $735,412 - $807,973	-19,611 Reduced 3.27%	580,355 $24.6 Million
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $85,634 - $97,632	2,226 Added 0.37%	599,966 $26.2 Million
Q3 2018 Oct 26, 2018	BUY	$34.47 - $41.81 $52,635 - $63,843	1,527 Added 0.26%	597,740 $26.3 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $267,335 - $285,006	-8,106 Reduced 1.34%	596,213 $21.6 Million
Q1 2018 Apr 30, 2018	SELL	$31.91 - $37.02 $59,575 - $69,116	-1,867 Reduced 0.31%	604,319 $21.4 Million
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $66,453 - $70,509	1,998 Added 0.33%	606,186 $22 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $60,264 - $66,387	1,944 Added 0.32%	604,188 $21.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	602,244	602,244 $20.2 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $162B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Account

Securian Asset Management, Inc Pfizer Inc Transaction History